Prestige Consumer Healthcare Inc.
PBH
Updated: 23/09/2026, 09:09:06
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
No summaries found.
- Share price
- $47.73
- Market cap
- $2.26B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Ronald Lombardi
- Employees
- 890
- IPO date
- 10/02/2005
- Beta
- 0.331
- Last dividend
- $0.00
- Day range
- $47.05 – $47.80
- 52-week range
- $42.62 – $71.07
- 1-day performance
- 1.99%
- 1-year performance
- 11.99%
- Current drawdown (1Y)
- -32.84%
- CIK
- 0001295947
- CUSIP
- 74112D101
- ISIN
- US74112D1019
- Created
- 07/12/2025, 05:41:15
- Last update
- 23/09/2026, 09:09:06
Track Prestige Consumer Healthcare Inc. with an AI analyst
See which prediction-market events move PBH, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Amylyx Pharmaceuticals Eyes Q3 Phase 3 Avexitide Readout as PBH Launch Plans Take Shape
MarketBeat • STOCK • 10/06/2026, 20:13:38
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
GlobeNewsWire • STOCK • 09/06/2026, 15:59:00
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm
PRNewsWire • STOCK • 08/06/2026, 14:19:00
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
GlobeNewsWire • STOCK • 02/06/2026, 18:30:00
Is the Options Market Predicting a Spike in Prestige Consumer Stock?
Zacks Investment Research • STOCK • 01/06/2026, 18:21:06
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
GlobeNewsWire • STOCK • 26/05/2026, 18:53:00
Protect Your Investment: Contact Levi & Korsinsky About the Prestige Consumer Healthcare Inc. (PBH) Investigation
Newsfile Corp • STOCK • 25/05/2026, 02:07:00
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm
Globe News Wire • STOCK • 24/05/2026, 17:00:06
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm
GlobeNewsWire • STOCK • 24/05/2026, 17:00:00
Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Business Wire • STOCK • 22/05/2026, 14:55:00
Prestige Consumer Healthcare, Inc. (PBH) Securities Fraud Investigation - Levi & Korsinsky
PRNewsWire • STOCK • 22/05/2026, 11:00:00
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH
PRNewsWire • STOCK • 21/05/2026, 20:40:00